GEA Pharma
Jürg Oleas, Chief Executive Officer of GEA Group Aktiengesellschaft, Richard Steiner, Business Development Manager for Continuous Processing of GEA Pharma Systems, Jan Vugts, Managing Director of GEA Pharma Systems, Belgium, and Anders Wilhjelm, President and CEO of GEA Process Engineering Segment.GEA Pharma Systems has won the GEA Innovation Award for its continuous direct compression technology, ConsiGma DC (CDC). CDC takes ingredients from powder to tablet in one step.
The GEA Innovation Award is an annual competition designed to celebrate and reward innovation throughout the organisation. Entrants are judged for their practicality and commercial potential with the winners being awarded additional funding to help with the development and promotion of the technology.
The CDC is a compact, all-in-one, tablet production line for direct compression formulations. It is a high-yield system that is sufficiently flexible to be able to handle bespoke production of small volume, high-value products and high-volume generic products on the same machine. It combines accurate feeding, blending, tablet compression and process analytics, all using patented GEA technologies.
Richard Steiner, Business Development Manager Continuous Processing for GEA Pharma Systems, recently presented the CDC concept to the GEA Board’s judging panel. The judges were impressed by the technology’s commercial benefits and business potential, recognising that the system provides the flexibility the pharmaceutical industry needs to meet growing volumes due to an increase in generics and a simultaneous increase in the demand for specialist medicines.
“We were all so pleased to win,” said Jan Vugts, Managing Director of GEA Pharma Systems in Wommelgem, “It will make a real difference to our plans to roll out the CDC worldwide. It’s exactly the right technology at exactly the right time.”
GEA Pharma Systems, +32 3 350 12 88, kris.schoeters@geagroup.com, www.geapharmasystems.com.